SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
26.00    2.50 (10.64%)
Bid:
25.00
Ask:
27.00
Spread: 2.00 (8.00%)
Market Cap: £12.38m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Trading Update

3 Feb 2020 07:00

RNS Number : 6618B
Pennant International Group PLC
03 February 2020
 

 

FOR IMMEDIATE RELEASE 3 February 2020 

PENNANT INTERNATIONAL GROUP PLC

 

Trading Update

 

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, announces the following trading update in respect of its financial year ending 31 December 2019 ("FY2019"). The Group's audited results for FY2019 are scheduled to be released on 23 March 2020.

 

Preliminary unaudited assessment of the Group's trading for FY2019 indicates that Pennant will report:

 

·; Revenues of circa £20 million;

·; Underlying earnings before interest, taxation and amortisation (EBITA) of circa £1.6 million;

·; Underlying earnings before interest, taxation, depreciation and amortisation (EBITDA) of circa £2.4 million;

·; Net debt at year-end of £2.2 million;

·; Three-year order book at year-end of £33 million of which circa £16 million is scheduled for delivery in 2020.

 

Underlying EBITA is stated after the add-back of a one-off restructuring expense and a charge relating to the impairment of the Group's freehold property portfolio (amounting to £0.7 million and £0.8 million respectively) both described in more detail below.

 

Impairment of freehold properties

 

In order to gear up for major contracts, the Group invested over £3 million in freehold property. The properties acquired are currently being utilised on the Qatar programme and on the helicopter maintenance trainer contract announced on 31 October 2019 and are necessary for the further expansion of the business.

 

Following a revaluation for the purposes of the annual accounts, it has become apparent that, due to the general softening of the commercial property market both locally and more broadly, certain of the properties are currently overvalued in the Company's books. While the net effect of the revaluation across Pennant's freehold portfolio is a reduction of £0.4 million (being an impairment of £0.8 million against certain properties and an increase in value of £0.4 million against others), due to applicable accounting standards the Group is required to expense the gross amount of the impairment (£0.8 million), which is regarded as non-underlying, with the upwards revaluations being credited to reserves.

 

Restructuring expense

 

As outlined in its announcement of 2 May 2019, the Group has been implementing a wide-ranging cost reduction exercise and various roles have been removed from the business. The aggregate cost associated with terminations of employment resulting from this exercise is £0.7 million which is regarded as a non-underlying expense.

 

It is anticipated that this programme will realise gross annualised savings of over £1 million. Taking into account new roles and capabilities implemented in the revised structure, the net annualised cost saving will be circa £0.6 million.

 

Strategy and Outlook

 

The Group continues to focus on its strategic objective of increasing the proportion of its revenues which derive from software and services, particularly those of a recurring nature.

 

Recent steps taken include an agreement to acquire Absolute Data Group (announced on 21 January 2020) which will form part of an enlarged, enhanced 'Integrated Logistics Support' offering as well as providing an increased presence in Pennant's target growth markets of North America and Australasia.

 

Pennant is actively considering other strategic opportunities to partner with or acquire complementary businesses and will continue to invest in developing its product range and its ability to deliver complementary services.

 

With a contracted order book of £33 million scheduled for delivery over the next three years, together with a sizeable pipeline of single-source opportunities, the Board remains confident of future prospects and of building and delivering long-term shareholder value.

 

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBNDBKBCBK
Date   Source Headline
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change
1st Nov 20211:23 pmRNSHolding in Company
28th Oct 20212:26 pmRNSHolding in Company
12th Oct 20212:44 pmRNSGrant of Option
30th Sep 20215:02 pmRNSHolding in Company
28th Sep 20214:31 pmRNSHolding in Company
27th Sep 20215:02 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSDirector/PDMR Share Purchases
22nd Sep 20217:00 amRNS2021 Interim Results
7th Sep 20212:44 pmRNSHolding in Company
31st Aug 20212:05 pmRNSSecond Price Monitoring Extn
31st Aug 20212:00 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSTrading Update & Notice of Interim Results
2nd Jun 20214:48 pmRNSResults of AGM & Appointment of new Chairman
27th May 20217:00 amRNSAGM Update
29th Apr 20213:31 pmRNSNotice of AGM
28th Apr 20212:05 pmRNSSecond Price Monitoring Extn
28th Apr 20212:00 pmRNSPrice Monitoring Extension
28th Apr 20217:00 amRNS2020 Final Results
19th Apr 20217:00 amRNSRescheduling of 2020 Final Results
1st Apr 20214:46 pmRNSIssue of Equity & Director Dealings
10th Mar 20217:00 amRNSNotice of Final Results
9th Mar 20217:00 amRNSHoldings in Company
9th Mar 20217:00 amRNSHoldings in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
5th Oct 202011:02 amRNSHolding(s) in Company
5th Oct 202011:01 amRNSHolding(s) in Company
5th Oct 202011:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNS2020 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.